CEPI
Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world. #100DaysMission
- This week CEPI is hosting a fictional pandemic simulation exercise in Seoul with Korea's Ministry of Food Drug & Safety, the Korea Disease Control and Prevention Agency and IVI. The expert meeting will explore opportunities to strengthen Korea's readiness to rapidly respond to a future viral threat⤵️
- 📣💡 With the prospect of protection against Lassa fever closer than ever before, CEPI and the West African Health Organization (WAHO) have launched the first end-to-end access roadmap for Lassa fever vaccines. Read more:
- The new Lassa end-to-end access roadmap is available to read in: English: bit.ly/4bTHpS3 French: bit.ly/4teMdHA
- Samsung Biologics becomes the latest organisation to join CEPI's Vaccine Manufacturing Facility Network (VMFN) -- a globally distributed manufacturing ecosystem designed to enable rapid and equitable access to vaccines in future pandemics. More: cepi.net/cepi-and-sam...
- Supported by up to US$20 million, CEPI will work with Samsung Biologics to establish a scalable, rapid manufacturing process for recombinant-protein vaccines.
- The aim is to pre-position a ready-to-activate process that can be deployed quickly when a new viral threat emerges, giving protein-based vaccines a rapid-response capability in future.
- By joining CEPI’s global VMFN, in a future pandemic situation, Samsung Biologics will provide CEPI with guaranteed access to up to potentially 50 million vaccine doses, and an additional one billion doses of drug substance ready to be converted into finished vaccines.
